Capstan Medical has successfully completed its first in-human, robot-assisted transcatheter mitral valve replacements.
The procedures were performed by Dr. Gonzalo Martinez at Hospital Clínico Universidad Católica in Santiago, Chile.
Capstan Medical's catheter-based treatment has the potential to transform how heart valve disease is treated, especially for patients who aren't candidates for conventional surgery.
Capstan Medical raised $110 million in Series C funding and plans to continue its plan for clinical and development work leading to upcoming trials.